Posted On: 01/13/2016 1:44:11 PM
Post# of 21197
$IMNP .53 Immune Pharmaceuticals Inc (NASDAQ:IMNP) has earned a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that cover the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy rating.
Brokerages have set a twelve-month consensus price objective of $6.38 for the company and are forecasting that the company will post ($0.16) EPS for the current quarter, according to Zacks. Zacks has also given Immune Pharmaceuticals an industry rank of 75 out of 265 based on the ratings given to its competitors. Read Full Article Here
http://www.americanbankingnews.com/2016/01/12...rokerages/
Brokerages have set a twelve-month consensus price objective of $6.38 for the company and are forecasting that the company will post ($0.16) EPS for the current quarter, according to Zacks. Zacks has also given Immune Pharmaceuticals an industry rank of 75 out of 265 based on the ratings given to its competitors. Read Full Article Here
http://www.americanbankingnews.com/2016/01/12...rokerages/
(0)
(0)Scroll down for more posts ▼
